<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1387311</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Machine learning and weighted gene co-expression network analysis identify a three-gene signature to diagnose rheumatoid arthritis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wu</surname>
<given-names>Ying-Kai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2659126"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Liu</surname>
<given-names>Cai-De</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Chao</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Jun</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xie</surname>
<given-names>Zong-Gang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Orthopaedic, The Second Affiliated Hospital of Soochow University</institution>, <addr-line>Jiangsu</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Orthopaedics, Ningyang County First People&#x2019;s Hospital</institution>, <addr-line>Tai an</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of General Practice, Affiliated Hospital of Weifang Medical University</institution>, <addr-line>Wei Fang</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Gynecology and Obstetrics, Ningyang County Maternal and Child Health Hospital</institution>, <addr-line>Tai an</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Medical Cosmetology and Plastic Surgery Center, LinYi People&#x2019;s Hospital</institution>, <addr-line>Lin Yi</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Jianan Zhao, Shanghai Guanghua Rheumatology Hospital, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Binbin Zhang, Affiliated Hospital of Hangzhou Normal University, China</p>
<p>Yuan Xu, China-Japan Friendship Hospital, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Zong-Gang Xie, <email xlink:href="mailto:8a145@163.com">8a145@163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1387311</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Wu, Liu, Liu, Wu and Xie</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Wu, Liu, Liu, Wu and Xie</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Rheumatoid arthritis (RA) is a systemic immune-related disease characterized by synovial inflammation and destruction of joint cartilage. The pathogenesis of RA remains unclear, and diagnostic markers with high sensitivity and specificity are needed urgently. This study aims to identify potential biomarkers in the synovium for diagnosing RA and to investigate their association with immune infiltration.</p>
</sec>
<sec>
<title>Methods</title>
<p>We downloaded four datasets containing 51 RA and 36 healthy synovium samples from the Gene Expression Omnibus database. Differentially expressed genes were identified using R. Then, various enrichment analyses were conducted. Subsequently, weighted gene co-expression network analysis (WGCNA), random forest (RF), support vector machine&#x2013;recursive feature elimination (SVM-RFE), and least absolute shrinkage and selection operator (LASSO) were used to identify the hub genes for RA diagnosis. Receiver operating characteristic curves and nomogram models were used to validate the specificity and sensitivity of hub genes. Additionally, we analyzed the infiltration levels of 28 immune cells in the expression profile and their relationship with the hub genes using single-sample gene set enrichment analysis.</p>
</sec>
<sec>
<title>Results</title>
<p>Three hub genes, namely, ribonucleotide reductase regulatory subunit M2 (<italic>RRM2</italic>), DLG-associated protein 5 (<italic>DLGAP5</italic>), and kinesin family member 11 (<italic>KIF11</italic>), were identified through WGCNA, LASSO, SVM-RFE, and RF algorithms. These hub genes correlated strongly with T cells, natural killer cells, and macrophage cells as indicated by immune cell infiltration analysis.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>
<italic>RRM2</italic>, <italic>DLGAP5</italic>, and <italic>KIF11</italic> could serve as potential diagnostic indicators and treatment targets for RA. The infiltration of immune cells offers additional insights into the underlying mechanisms involved in the progression of RA.</p>
</sec>
</abstract>
<kwd-group>
<kwd>rheumatoid arthritis</kwd>
<kwd>hub genes</kwd>
<kwd>machine learning</kwd>
<kwd>immune cell infiltration</kwd>
<kwd>WGCNA</kwd>
</kwd-group>
<contract-sponsor id="cn001">Health Commission of Shandong Province<named-content content-type="fundref-id">10.13039/501100020206</named-content>
</contract-sponsor>
<counts>
<fig-count count="10"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="43"/>
<page-count count="13"/>
<word-count count="4278"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation, proliferation of synovial membranes, and cartilage destruction, which has a serious impact on the physical and mental health of patients (<xref ref-type="bibr" rid="B1">1</xref>). Although RA does not directly lead to the mortality of patients, its systemic inflammatory damage can affect the function of organs such as the heart, lungs, and kidneys, reducing the quality of the patient&#x2019;s life (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). The pathogenesis of RA is complex and involves multiple factors such as genetics, environment, and metabolism. Moreover, the exact mechanisms associated with these factors and RA have not yet been systematically determined (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). According to recent research, different types of immune cells, such as B cells, T cells, and macrophages, are closely associated with the development of RA (<xref ref-type="bibr" rid="B6">6</xref>). Other immune cells, including natural killer (NK) cells, mast cells, and dendritic cells (DCs) also play an important role in the development or advancement of RA (<xref ref-type="bibr" rid="B7">7</xref>&#x2013;<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>Currently, studies on the treatment and pathogenesis of RA are increasing, but there is still a lack of highly specific and sensitive biomarkers for its early diagnosis. Bioinformatics is a discipline that combines biology, mathematics, and information technology and plays a prominent role in disease detection, biomarker identification, high-risk patient identification, and so on (<xref ref-type="bibr" rid="B10">10</xref>). Weighted gene co-expression network analysis (WCGNA) is a common method of identifying disease biomarkers and treatment targets. Machine learning algorithms, a subset of artificial intelligence that allows computers to learn from data and predict genes associated with disease, are also widely used in research (<xref ref-type="bibr" rid="B11">11</xref>). In our study, bioinformatics and three machine learning algorithms were comprehensively applied to integrate and analyze multiple expression datasets. This approach allowed the identification of highly sensitive and specific biomarkers and treatment targets and would provide new directions for subsequent experimental research. In this study, the expression matrix of four synovium samples was downloaded, the intersection genes were obtained by difference analysis and WGCNA, and then hub genes were identified by least absolute shrinkage and selection operator (LASSO), support vector machine&#x2013;recursive feature elimination (SVM-RFE), and random forest (RF) machine learning algorithms, and their diagnostic efficiency was validated. Additionally, we analyzed the infiltration levels of 28 immune cells in the expression profile and their relationship with hub genes using single-sample gene set enrichment analysis (ssGSEA).</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Data collection and preprocessing</title>
<p>The steps in the analysis of the entire research are shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>. First, we obtained gene expression datasets of RA synovial samples (GSE77298, GSE55235, GSE12021, and GSE55457) from the Gene Expression Omnibus (GEO) database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>) (<xref ref-type="bibr" rid="B12">12</xref>). These datasets included 87 synovial samples (36 normal control samples and 51 RA samples) (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). GSE55457 was used as an external validation dataset, whereas the other datasets were merged and normalized for data analysis as a training set using the sva package (<xref ref-type="bibr" rid="B13">13</xref>). Common genes across each dataset were identified for further analysis.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The flowchart depicting the investigation procedure. GSEA, gene set enrichment analysis; GSVA, gene set variation analysis; WGCNA, weighted gene co-expression network construction analysis; DEGs, differentially expressed genes; ssGSEA, single-sample gene set enrichment analysis; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; LASSO, least absolute shrinkage and selection operator; RF, random forest; SVM-RFE, support vector machine&#x2013;recursive feature elimination; ROC, receiver operating characteristic curve; TFs, transcription factors; miRNAs, microRNAs; DCA, decision curve analysis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1387311-g001.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Information of datasets obtained from GEO.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Datasets</th>
<th valign="top" align="left">Platform</th>
<th valign="top" align="left">Total sample number</th>
<th valign="top" align="left">Normal sample number</th>
<th valign="top" align="left">RA sample number</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">GSE55235</td>
<td valign="top" align="left">GLP96</td>
<td valign="top" align="left">30</td>
<td valign="top" align="left">10</td>
<td valign="top" align="left">10</td>
</tr>
<tr>
<td valign="top" align="left">GSE77298</td>
<td valign="top" align="left">GLP96</td>
<td valign="top" align="left">23</td>
<td valign="top" align="left">7</td>
<td valign="top" align="left">16</td>
</tr>
<tr>
<td valign="top" align="left">GSE12021</td>
<td valign="top" align="left">GLP96</td>
<td valign="top" align="left">21</td>
<td valign="top" align="left">9</td>
<td valign="top" align="left">12</td>
</tr>
<tr>
<td valign="top" align="left">GSE55457</td>
<td valign="top" align="left">GLP570</td>
<td valign="top" align="left">33</td>
<td valign="top" align="left">10</td>
<td valign="top" align="left">13</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Identification of differentially expressed genes and enrichment analyses</title>
<p>Differentially expressed genes (DEGs) were identified using the limma package with |log Fold Change (FC)| &#x2265; 1 and <italic>P</italic>-value &lt; 0.05 used as the cutoff for filtering the DEGs (<xref ref-type="bibr" rid="B14">14</xref>). DEGs were visualized using a heatmap and volcano map obtained by using pheatmap and ggplot2 packages. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were conducted with a cutoff of <italic>P</italic> &lt; 0.05 (<xref ref-type="bibr" rid="B15">15</xref>). A gene set variation analysis (GSVA) was performed using the GSVA R package to calculate a normalized enrichment score under the background of the hallmark gene set (c2.cp.kegg.v7.2) with the thresholds of the <italic>P</italic>-value and false discovery rate (FDR) set as 0.05 and 0.25, respectively (<xref ref-type="bibr" rid="B16">16</xref>). We also used GSEA to identify the biological attributes and functions of all genes in the training set by using clusterProfiler in the R package with significant thresholds selected as <italic>P</italic>-value &lt; 0.05 and FDR &lt; 0.25 (<xref ref-type="bibr" rid="B17">17</xref>).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Construction of the co-expression network</title>
<p>The WGCNA package was used to construct a weighted gene co-expression network (<xref ref-type="bibr" rid="B18">18</xref>). The samples were organized into clusters to identify outliers. Then, pairwise correlations were calculated between genes and a weighted adjacency matrix was constructed using a soft thresholding power &#x3b2;. The hierarchical clustering method was used to construct the clustering tree structure of the TOM(Topological overlap matrix). Different branches of the cluster tree represented different gene modules whcic were screened by different colours. To establish a link between modules and clinical characteristics, estimations of module membership (MM) and gene significance (GS) were computed. The modules with the highest Pearson coefficient and <italic>P</italic> &lt; 0.05 were used to select the candidate hub genes under the criterion of MM &gt; 0.8 and GS &gt; 0.5.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Identifying hub genes</title>
<p>The Venn package was used to obtain intersecting DEGs and WGCNA candidate hub genes. LASSO logistic regression analysis was conducted using the R package glmnet with the optimal minimal lambda identified. Our study validated the selection of optimization parameters through 10-fold cross-validation, ensuring that the partial likelihood deviation satisfied the minimum criteria. The e1071 package was used to conduct the SVM-RFE with five-fold cross-validation, and the RF algorithm of the RF package was used to analyze the intersection genes. Ultimately, hub genes were obtained by identifying the overlapping genes derived from the three machine learning methods using a Venn diagram.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Constructing nomogram model and validation of hub genes</title>
<p>A nomogram for predicting RA was constructed using the rms package (<xref ref-type="bibr" rid="B19">19</xref>). The predictive power of the nomogram model was assessed using a calibration curve. A decision curve was used to assess the clinical utility of the nomogram model. A receiver operating characteristic (ROC) curve was created using the R package pROC function to determine the diagnostic value of the hub genes and the nomogram model for RA in the training and validation sets.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Correlation between immune cell infiltration and hub genes</title>
<p>The relative infiltration levels of 28 immune cells in the training set were quantified using the ssGSEA algorithm (<xref ref-type="bibr" rid="B20">20</xref>). Barplots were used to show the differential expression levels of 28 immune-infiltrating cells. Spearman correlations of 28 immune-infiltrating cells with hub genes were calculated and then visualized using the ggplot2 package.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Co-expression network of identified hub genes</title>
<p>GeneMANIA (<ext-link ext-link-type="uri" xlink:href="https://genemania.org">https://genemania.org</ext-link>) was used to create a hub gene co-expression network (<xref ref-type="bibr" rid="B21">21</xref>).</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Functional enrichment analysis of hub genes</title>
<p>The online tool Enrichr (<xref ref-type="bibr" rid="B22">22</xref>) (<ext-link ext-link-type="uri" xlink:href="https://maayanlab.cloud/Enrichr/">https://maayanlab.cloud/Enrichr/</ext-link>) was used to determine the biological process (BP), cellular component (CC), molecular function (MF), KEGG, WikiPathways, and Reactome enrichment analysis of the three hub genes (<xref ref-type="bibr" rid="B19">19</xref>). The significant threshold was adj. <italic>P</italic>-value &lt; 0.05.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Transcription factors and microRNAs associated with the three hub genes</title>
<p>The JASPAR (<ext-link ext-link-type="uri" xlink:href="https://jaspar.elixir.no/">https://jaspar.elixir.no/</ext-link>) database was used to find the transcription factors (TFs) that frequently bind to the three hub genes. MicroRNA (miRNAs) that interact with the hub genes were obtained from an online platform MirTarbase (<ext-link ext-link-type="uri" xlink:href="https://mirtarbase.cuhk.edu.cn/">https://mirtarbase.cuhk.edu.cn/</ext-link>).</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Suppressive potential of small molecules in RA</title>
<p>We accessed the DSigDB (version 1.0) database through the Enrichr platform and obtained the top 10 small molecules that could suppress the expression of hub genes.</p>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Statistical analysis</title>
<p>The statistical software R version 4.3.4 was used to perform statistical analysis, with <italic>P</italic>-values of &lt; 0.05 indicating statistical significance.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>DEG identification</title>
<p>A total of 575 DEGs (including 383 upregulated genes and 192 downregulated genes) were identified between RA and normal samples. The top 10 upregulated and downregulated DEGs are presented in a volcano plot (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). In addition, the expression levels of the 25 most upregulated and 25 most downregulated genes are shown in a heatmap (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Identifications of RA hub genes. <bold>(A)</bold> Volcano plot and <bold>(B)</bold> heatmap present the identified DEGs between patients with RA and normal controls (|Iog FC| &gt; 1 and adjusted p-value &lt; 0.05 were defined as six screening standard to obtain DEGs). RA, rheumatoid arthritis; DEGs, differentially expressed genes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1387311-g002.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Functional enrichment analysis</title>
<p>DEGs in the BP category of GO were enriched in mononuclear cell differentiation, leukocyte cell&#x2013;cell, and immune response&#x2013;regulating cell surface receptor signaling pathways. In the MF category, DEGs were mostly related to antigen binding, immune receptor activity, and chemokine activity. In the CC category, DEGs were mostly assigned to the external side of the plasma membrane and clathrin-coated vesicle membrane (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). KEGG pathway analysis showed that DEGs were enriched in cytokine&#x2013;cytokine receptor interaction, chemokine signaling pathway, and RA; GSEA analysis produced similar results (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). GSEA was used to depict the signal pathways involved in RA. The top five pathways enriched by DEGs were the chemokine signaling, cytokine&#x2013;cytokine receptor interaction, intestinal immune network for Immunoglobulin A (IgA) production, RA, viral protein interactions with cytokines, and cytokine (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). In the RA group, the GSVA results of enriched DEGs also indicated that immunity and inflammation pathways, such as chemokine signaling, NK cell&#x2013;mediated immunity, B-cell receptor signaling, primary immunodeficiency, and intestinal immune network for IgA production were evident (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>GO, KEGG, GSEA, and GSVA analyses based on GSE55235, GSE12021, and GSE77298. <bold>(A)</bold> Bubble diagram showing the GO enrichment analysis of DEGs. <bold>(B)</bold> Bubble diagram showing the KEGG enrichment analysis of DEGs. <bold>(C)</bold> GSEA analysis. <bold>(D)</bold> GSVA analysis. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes; BP, biological process; MF, molecular function; CC, cellular component; GSEA, gene set enrichment analysis; GSVA, gene set variation analysis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1387311-g003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>WGCNA construction and hub module identification</title>
<p>Samples in the training set were clustered using the WGCNA package. Subsequently, the unscaled connectivity index was determined, and an average connectivity analysis was conducted. When the soft threshold &#x3b2; = 8, the network reached an unscaled topological threshold of 0.9 (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). By dynamic tree cutting and calculation, 11 gene modules were obtained (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). Correlation analysis was performed between the 11 modules and the normal and RA groups, resulting in a correlation heatmap (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). The salmon module had the strongest correlation with the RA (r = 0.73, <italic>P</italic> &lt; 0.001) and was identified as the key module for RA. Based on filtering criteria, we identified 17 candidate hub genes in the salmon module (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>WGCNA analysis and hub candidates for RA. <bold>(A)</bold> Analysis of the mean connectivity and scale-free fit index for different soft-thresholding powers (&#x3b2;). Where the correlation coefficient is 0.9 and the matching soft-thresholding power is 8, the red line represents this location. <bold>(B)</bold> The cluster dendrogram of the top 25% of genes median absolute deviations. Each hue in the graphic below corresponds to a co-expression module, and each branch in the figure represents a single gene. <bold>(C)</bold> Heatmap illustrating the relationships between modules and traits. The salmon module has a strong correlation with RA. <bold>(D)</bold> Scatter plot showing the relationship between the genes relevance and its inclusion in the salmon module of genes. WGCNA, weighted gene co-expression network analysis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1387311-g004.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Screening of hub genes</title>
<p>By intersecting the DEGs and candidate hub genes, 13 intersection genes were obtained (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). The 13 intersection genes were then submitted into three machine learning algorithms including LASSO, SVM-RFE, and RF. LASSO resulted in four hub genes (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5B, C</bold>
</xref>), SVM identified five hub genes (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>), and RF identified seven hub genes (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5E, F</bold>
</xref>). Finally, we obtained three hub genes ribonucleotide reductase regulatory subunit M2 (<italic>RRM2</italic>), DLG-associated protein 5 (<italic>DLGAP5</italic>), and kinesin family member 11 (<italic>KIF11</italic>) by intersecting the three machine learning results (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5G</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Screening of hub genes. <bold>(A)</bold> Venn diagram for overlapped genes between DEGs and WGCNA. <bold>(B)</bold> The LASSO regression partial likelihood deviance with changing log (&#x3bb;) plotted in 10-fold cross-validations. Dotted vertical lines were drawn at the optimal values using the minimum criteria (lambda.min) and 1 standard error of the minimum criteria (1-SE criteria). <bold>(C)</bold> The LASSO coefficient profiles for four hub genes in the 10-fold cross-validation. The intersection of <bold>(D)</bold> five gene signatures was identified by SVM-RFE analysis. <bold>(E)</bold> Prediction accuracy of the RandomForest model. <bold>(F)</bold> Seven gene signatures were identified by RandomForest analysis. <bold>(G)</bold> Overlapped genes obtained from the LASSO, SVM-RFE, and random forest algorithms. DEGs, differentially expressed genes; WGCNA, weighted gene co-expression network analysis; LASSO, least absolute shrinkage and selection operator; SVM-REF, support vector machine&#x2013;recursive feature elimination.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1387311-g005.tif"/>
</fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Constructing the nomogram model and validation</title>
<p>A nomogram model was then constructed using the three hub genes in the training set to predict the risk of RA (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>). The nomogram model was found to have the best predictive and clinical efficiency for RA by calibration curves (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>) and decision curve analysis (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>), respectively. The area under the ROC curve (AUC) of the nomogram model and three hub genes were also calculated (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6D, E</bold>
</xref>). Next, we constructed a validation set using all the procedures, which showed a perfect match with the resultsin the training set. To further validate this result, we obtained RNA-seq data on the synovium of patients with RA and osteoarthritis (OA) uploaded to GitHub by Shanghai Guanghua Hospital (<xref ref-type="bibr" rid="B23">23</xref>) and analyzed the expression levels of key genes in the data. Consistent with this study, we found that the expression levels of three hub genes in RA synovium were significantly higher than in OA synovium (<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Nomogram model construction for RA diagnosis. <bold>(A)</bold> Nomogram to predict RA risk. <bold>(B)</bold> Calibration curve evaluation for the diagnostic potential of the nomogram model. <bold>(C)</bold> DCA curve to assess the nomogram practical efficacy. <bold>(D)</bold> ROC analysis of the model. <bold>(E)</bold> ROC analysis of three hub genes. DCA, decision curve analysis; ROC, receiver operating characteristic; AUC, area under the ROC curve (based on GSE77298, GSE55235, and GSE12021).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1387311-g006.tif"/>
</fig>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Nomogram model construction for RA diagnosis. <bold>(A)</bold> Nomogram to predict RA risk. <bold>(B)</bold> Calibration curve evaluation for the diagnostic potential of the nomogram model. <bold>(C)</bold> DCA curve to assess the nomogram practical efficacy. <bold>(D)</bold> ROC analysis of the model. <bold>(E)</bold> ROC analysis of three hub genes. <bold>(F)</bold> Expression level of hub genes according to datasets from GitHub by Shanghai Guanghua Hospital. DCA, decision curve analysis; ROC, receiver operating characteristic; AUC, area under the ROC curve (based on GSE55457).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1387311-g007.tif"/>
</fig>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Correlation between the immune cell infiltration and hub genes</title>
<p>The distribution of 28 immune cells in the training set is demonstrated in <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>. In our results, a significantly higher infiltration of activated CD4 T cells, activated B cells, and activated DC infiltration was found in RA, indicating the important role that they play in the disease (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>). Correlation analysis of the 28 immune cells with hub genes demonstrated that various T cells, B cells, NK cells, and macrophages were positively correlated with the three hub genes (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8C</bold>
</xref>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Analyses of the OA-related immunological environment. The distribution of 28 different types of immune cells in healthy control and OA synovial tissues is shown in a heatmap <bold>(A)</bold> and a violin plot <bold>(B)</bold>. <bold>(C)</bold> The association between immune cells infiltration and four hub genes.  ****, ***, **, * represented P&lt;0.0001, P&lt;0.001, P&lt;0.01, P&lt;0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1387311-g008.tif"/>
</fig>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Function analysis of hub genes</title>
<p>To analyze the biological functions of the identified hub genes, we constructed a comprehensive gene interaction network using data from the gene MANIA database (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9A</bold>
</xref>). This network comprised physical interactions, co-expression relationships, predicted interactions, co-localization patterns, genetic interactions, pathway interactions, and shared protein domains. Our findings indicate that the hub genes are primarily associated with mitotic nuclear division, spindle, and microtubule cytoskeleton organization involved in mitosis and spindle organization. Furthermore, to discern the specific biological roles of the three hub genes, we conducted an enrichment analysis. In <xref ref-type="fig" rid="f9">
<bold>Figures&#xa0;9B&#x2013;D</bold>
</xref>, we illustrate the most enriched terms in the CC, BP, and MF analyses of GO terms. Additionally, <xref ref-type="fig" rid="f9">
<bold>Figures&#xa0;9E&#x2013;G</bold>
</xref> depict the most significant pathways based on data from the Reactome, Wiki Pathway, and KEGG databases, respectively.</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>
<bold>(A)</bold> Co-expression network of hub genes. Hub genes and their co-expression genes were analyzed via GeneMANIA. <bold>(B)</bold> Significantly enriched cellular components. <bold>(C)</bold> Significantly enriched biological processes. <bold>(D)</bold> Significantly enriched molecular functions. GO, Gene Ontology. <bold>(E)</bold> Reactome pathway, <bold>(F)</bold> WikiPathway, and <bold>(G)</bold> KEGG 2021 human pathway. KEGG, Kyoto Encyclopedia of Genes and Genomes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1387311-g009.tif"/>
</fig>
</sec>
<sec id="s3_8">
<label>3.8</label>
<title>Identification of regulatory signatures</title>
<p>The interplay between the three hub genes and TF regulators is depicted in <xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10A</bold>
</xref>, whereas the relationships between the hub genes and miRNA regulators are illustrated in <xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10B</bold>
</xref>. In total, we identified 18 TFs and 17 miRNAs as regulatory signatures by analyzing TF&#x2013;gene and miRNA&#x2013;gene interaction networks.</p>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>The cohesive regulatory interaction network of three hub genes and TFs and miRNAs obtained from the Network Analyst. <bold>(A)</bold> Genes and TFs. <bold>(B)</bold> Genes and miRNAs. Herein, the diamond nodes are TFs; the square node indicates miRNAs; gene symbols as circle nodes. TF, transcription factors; miRNAs, microRNAs.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1387311-g010.tif"/>
</fig>
</sec>
<sec id="s3_9">
<label>3.9</label>
<title>Discovery of potential small molecules</title>
<p>We generated potential small-molecule findings based on odds ratios. <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref> presents the top 10 small molecules that could potentially target the hub genes sourced from the DSigDB database.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Top 10 small-molecule drugs for RA.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Term</th>
<th valign="middle" align="left">Overlap</th>
<th valign="middle" align="left">P-value</th>
<th valign="middle" align="left">Adjusted P-value</th>
<th valign="middle" align="left">Odds ratio</th>
<th valign="middle" align="left">Combined score</th>
<th valign="middle" align="left">Genes</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">LUCANTHONE CTD 00006227</td>
<td valign="middle" align="left">3/213</td>
<td valign="middle" align="left">1.19E-06</td>
<td valign="middle" align="left">1.86E-04</td>
<td valign="middle" align="left">59361</td>
<td valign="middle" align="left">809723.5033</td>
<td valign="middle" align="left">RRM2;KIF11;DLGAP5</td>
</tr>
<tr>
<td valign="middle" align="left">0173570-0000 PC3 DOWN</td>
<td valign="middle" align="left">2/43</td>
<td valign="middle" align="left">1.35E-05</td>
<td valign="middle" align="left">5.35E-04</td>
<td valign="middle" align="left">973.4634146</td>
<td valign="middle" align="left">10913.3726</td>
<td valign="middle" align="left">KIF11;DLGAP5</td>
</tr>
<tr>
<td valign="middle" align="left">Phytoestrogens CTD 00007437</td>
<td valign="middle" align="left">2/48</td>
<td valign="middle" align="left">1.69E-05</td>
<td valign="middle" align="left">5.35E-04</td>
<td valign="middle" align="left">867.4347826</td>
<td valign="middle" align="left">9531.856143</td>
<td valign="middle" align="left">RRM2;DLGAP5</td>
</tr>
<tr>
<td valign="middle" align="left">Etoposide MCF7 DOWN</td>
<td valign="middle" align="left">2/48</td>
<td valign="middle" align="left">1.69E-05</td>
<td valign="middle" align="left">5.35E-04</td>
<td valign="middle" align="left">867.4347826</td>
<td valign="middle" align="left">9531.856143</td>
<td valign="middle" align="left">KIF11;DLGAP5</td>
</tr>
<tr>
<td valign="middle" align="left">Methotrexate MCF7 DOWN</td>
<td valign="middle" align="left">2/52</td>
<td valign="middle" align="left">1.99E-05</td>
<td valign="middle" align="left">5.35E-04</td>
<td valign="middle" align="left">797.88</td>
<td valign="middle" align="left">8638.620968</td>
<td valign="middle" align="left">KIF11;DLGAP5</td>
</tr>
<tr>
<td valign="middle" align="left">Piroxicam CTD 00006571</td>
<td valign="middle" align="left">3/549</td>
<td valign="middle" align="left">2.06E-05</td>
<td valign="middle" align="left">5.35E-04</td>
<td valign="middle" align="left">58353</td>
<td valign="middle" align="left">629719.0634</td>
<td valign="middle" align="left">RRM2;KIF11;DLGAP5</td>
</tr>
<tr>
<td valign="middle" align="left">Troglitazone CTD 00002415</td>
<td valign="middle" align="left">3/651</td>
<td valign="middle" align="left">3.43E-05</td>
<td valign="middle" align="left">7.65E-04</td>
<td valign="middle" align="left">58047</td>
<td valign="middle" align="left">596691.1364</td>
<td valign="middle" align="left">RRM2;KIF11;DLGAP5</td>
</tr>
<tr>
<td valign="middle" align="left">Apigenin MCF7 DOWN</td>
<td valign="middle" align="left">2/87</td>
<td valign="middle" align="left">5.60E-05</td>
<td valign="middle" align="left">0.0010851</td>
<td valign="middle" align="left">468.5176471</td>
<td valign="middle" align="left">4587.228583</td>
<td valign="middle" align="left">RRM2;KIF11</td>
</tr>
<tr>
<td valign="middle" align="left">Pyrvinium MCF7 DOWN</td>
<td valign="middle" align="left">2/92</td>
<td valign="middle" align="left">6.26E-05</td>
<td valign="middle" align="left">0.0010851</td>
<td valign="middle" align="left">442.3777778</td>
<td valign="middle" align="left">4281.648144</td>
<td valign="middle" align="left">RRM2;KIF11</td>
</tr>
<tr>
<td valign="middle" align="left">Resveratrol MCF7 DOWN</td>
<td valign="middle" align="left">2/104</td>
<td valign="middle" align="left">8.01E-05</td>
<td valign="middle" align="left">0.001249052</td>
<td valign="middle" align="left">390.0980392</td>
<td valign="middle" align="left">3679.655006</td>
<td valign="middle" align="left">KIF11;DLGAP5</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>RA is a chronic inflammatory disease that currently lacks early diagnostic indicators (<xref ref-type="bibr" rid="B6">6</xref>). Recent studies have highlighted the close association of various immune cells, such as B cells, T cells, and macrophages, with the pathogenesis of RA (<xref ref-type="bibr" rid="B24">24</xref>). Therefore, the exploration of new diagnostic biomarkers and their relationship with immune cell infiltration patterns holds significant implications for advancing our understanding of RA pathophysiology. To address this, we gathered four RA synovial microarray datasets from the GEO database and identified 575 DEGs between RA and healthy controls. Enrichment analyses, GO, KEGG, GSEA, and GSVA revealed a robust correlation between RA and the immune response.</p>
<p>Fibroblast-like synoviocytes (FLSs) are the most abundant cells of the stroma and a key population in RA. Recent research indicates that the interaction between RA FLSs and infiltrating immune cells is pivotal in chronic inflammation and bone degradation. Specifically, CD4+ T helper cells, T helper cell 1 (Th1) and T helper cell 17  (Th17) cells, produce cytokines that either inhibit or stimulate osteoclast formation, impacting bone health. The involvement of T cells in bone loss was first demonstrated in 1999, highlighting their role in promoting osteoclastogenesis and subsequent bone erosion. Studies using mouse models further support the significance of Th17 cells and Interleukin-17 (IL-17) in bone damage, with therapeutic interventions targeting IL-17 showing promise but not leading to complete disease remission in patients with RA (<xref ref-type="bibr" rid="B25">25</xref>).</p>
<p>Our findings revealed that macrophages play an important role in the infiltration of immune cells in the synovium. In contrast to tissue-resident macrophages, infiltrating macrophages may originate from various monocyte subpopulations in the blood and possess a high level of adaptability. For instance, in mice, they can arise from classical Ly6C+ or patrolling Ly6C<sup>&#x2212;</sup> monocytes (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). In a recent comprehensive analysis of immune cell status in patients with RA, single-cell RNA-seq, bulk RNA-seq, and mass spectrometry flow cytometry were used to identify 18 distinct synoviocyte populations, including four monocyte/macrophage populations denoted as SC-M1 to SC-M4 (<xref ref-type="bibr" rid="B28">28</xref>). This analysis demonstrated that the activation of different cytokines promoted the expansion of diverse macrophage subpopulations in the RA synovium. Furthermore, as the primary orchestrators of the immune response, DCs can secrete chemokines that facilitate the activation of inflammatory T cells, thereby attracting proinflammatory immune cells such as macrophages and neutrophils (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B31">31</xref>). <italic>In vitro</italic>, RA synovial DCs have the potential to induce regulatory T (Treg) cells through the prolonged engagement of programmed cell death 1 receptors (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Although Treg cells in the peripheral blood of patients with RA retain inhibitory capacity, this function is compromised in local Treg cells, suggesting that the inflammatory cytokine environment may contribute to Treg cell dysfunction (<xref ref-type="bibr" rid="B34">34</xref>).</p>
<p>Through the use of WGCNA and machine learning algorithms, we identified <italic>DLGAP5</italic>, <italic>RRM2</italic>, and <italic>KIF11</italic> as potential diagnostic markers for RA. <italic>RRM2</italic> plays a critical role in controlling the production of deoxyribonucleotides, which is essential for DNA repair and synthesis (<xref ref-type="bibr" rid="B35">35</xref>). Blocking <italic>RRM2</italic> has a substantial impact on reducing cellular growth and triggering cell death (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>). Recently, other studies have demonstrated that <italic>RRM2</italic> could increase the levels of apoptosis and inhibit the proliferation of RA-FLSs by regulating transforming growth factor-&#x3b2; (TGF-&#x3b2;) and IL-6 (<xref ref-type="bibr" rid="B38">38</xref>).</p>
<p>Although several bioinformatics methodologies have been used to investigate potential biomarkers for RA, there is limited literature regarding the involvement of <italic>DLGAP5</italic> in the pathophysiology of this condition (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). Previous investigations have examined the structure and function of <italic>DLGAP5</italic> across various species, considering both physiological and clinicopathological perspectives. These studies have revealed that <italic>DLGAP5</italic> plays a crucial role in facilitating cell growth, proliferation, and migration (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>). Therefore, this presents an opportunity to investigate in further detail the potential of <italic>DLGAP5</italic> in diagnosing and differentially diagnosing RA, as well as its role in the pathophysiology of the disease.</p>
<p>
<italic>KIF11</italic> encodes a motor protein belonging to the kinesin-like protein family, which is recognized for its involvement in diverse spindle dynamics. The role of the gene product encompasses chromosome positioning, centrosome separation, and the establishment of a bipolar spindle during cell mitosis (<xref ref-type="bibr" rid="B43">43</xref>). However, there is limited literature on the role of KIF11 in the RA joint microenvironment. Therefore, in this study, <italic>KIF11</italic> along with the two other hub genes performed a diagnosis of RA with optimal sensitivity and specificity.</p>
<p>This study has several limitations. First, the dataset obtained from the GEO database lacks comprehensive patient information, including serological and imaging indicators. As a result, we were unable to evaluate the correlation of biomarkers or immune cells with clinical characteristics such as hematological indicators, degree of joint destruction, and treatment status in patients with RA. More detailed data are necessary for the further exploration of the clinical significance of the biomarkers. Second, the biomarker discovery was based on the GEO database. Despite the satisfactory performance of our biomarkers in both test and validation datasets, additional <italic>in vitro</italic> and <italic>in vivo</italic> experiments are required to validate our findings and determine the mechanisms underlying significant immunological changes during RA.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>Using LASSO, SVM-RFE, and RF algorithms in conjunction with bioinformatic analyses, we identified a three-gene signature (<italic>RRM2, DLGAP5</italic>, and <italic>KIF11</italic>) implicated in the progression of RA. Immune infiltration analyses revealed that the identified hub genes exhibited the strongest correlation with various T cells, B cells, NK cells, and macrophages. To confirm our identification of diagnostic markers with high sensitivity and specificity for RA, prospective large-sample investigations with experimental validation should be conducted.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Ethical approval was not required for the study involving humans in accordance with the local legislation and institutional requirements. Written informed consent to participate in this study was not required from the participants or the participants&#x2019; legal guardians/next of kin in accordance with the national legislation and the institutional requirements. The manuscript presents research on animals that do not require ethical approval for their study.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>Y-KW: Writing &#x2013; original draft. C-DL: Data curation, Writing &#x2013; review &amp; editing. CL: Formal analysis, Writing &#x2013; review &amp; editing. JW: Formal analysis, Writing &#x2013; review &amp; editing. Z-GX: Supervision, Validation, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Shandong Province Medicine and Health Development Plan (202205010700) and the Linyi Natural Science Foundation (2022YX0053).</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zulipikaer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of PSMB9 and CXCL13 as immune-related diagnostic markers for rheumatoid arthritis by machine learning</article-title>. <source>Curr Pharm Des</source>. (<year>2022</year>) <volume>28</volume>:<page-range>2842&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1381612828666220831085608</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>Rheumatoid arthritis: pathogenic roles of diverse immune cells</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23020905</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuroda</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tanabe</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kobayashi</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wada</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Murakami</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis</article-title>. <source>J Rheumatol</source>. (<year>2012</year>) <volume>39</volume>:<page-range>1348&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3899/jrheum.111453</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Firestein</surname> <given-names>GS</given-names>
</name>
<name>
<surname>McInnes</surname> <given-names>IB</given-names>
</name>
</person-group>. <article-title>Immunopathogenesis of rheumatoid arthritis</article-title>. <source>Immunity</source>. (<year>2017</year>) <volume>46</volume>:<page-range>183&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2017.02.006</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karami</surname> <given-names>J</given-names>
</name>
<name>
<surname>Aslani</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jamshidi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Garshasbi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mahmoudi</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review</article-title>. <source>Gene</source>. (<year>2019</year>) <volume>702</volume>:<fpage>8</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.gene.2019.03.033</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yap</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Tee</surname> <given-names>SZ</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Chow</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Peh</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Teow</surname> <given-names>SY</given-names>
</name>
</person-group>. <article-title>Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development</article-title>. <source>Cells</source>. (<year>2018</year>) <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells7100161</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivellese</surname> <given-names>F</given-names>
</name>
<name>
<surname>Nerviani</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rossi</surname> <given-names>FW</given-names>
</name>
<name>
<surname>Marone</surname> <given-names>G</given-names>
</name>
<name>
<surname>Matucci-Cerinic</surname> <given-names>M</given-names>
</name>
<name>
<surname>de Paulis</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Mast cells in rheumatoid arthritis: friends or foes</article-title>? <source>Autoimmun Rev</source>. (<year>2017</year>) <volume>16</volume>:<page-range>557&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.autrev.2017.04.001</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hilkens</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Isaacs</surname> <given-names>JD</given-names>
</name>
</person-group>. <article-title>Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now</article-title>? <source>Clin Exp Immunol</source>. (<year>2013</year>) <volume>172</volume>:<page-range>148&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cei.12038</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Langridge</surname> <given-names>WHR</given-names>
</name>
</person-group>. <article-title>The function of myeloid dendritic cells in rheumatoid arthritis</article-title>. <source>Rheumatol Int</source>. (<year>2017</year>) <volume>37</volume>:<page-range>1043&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00296-017-3671-z</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>DD</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>PY</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>L</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>QH</given-names>
</name>
</person-group>. <article-title>Bioinformatic identification and validation of autophagy-related genes in rheumatoid arthritis</article-title>. <source>Clin Rheumatol</source>. (<year>2023</year>) <volume>42</volume>:<page-range>741&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10067-022-06399-2</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auwul</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Rahman</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Gov</surname> <given-names>E</given-names>
</name>
<name>
<surname>Shahjaman</surname> <given-names>M</given-names>
</name>
<name>
<surname>Moni</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19</article-title>. <source>Brief Bioinform</source>. (<year>2021</year>) <volume>22</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bib/bbab120</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edgar</surname> <given-names>R</given-names>
</name>
<name>
<surname>Domrachev</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lash</surname> <given-names>AE</given-names>
</name>
</person-group>. <article-title>Gene Expression Omnibus: NCBI gene expression and hybridization array data repository</article-title>. <source>Nucleic Acids Res</source>. (<year>2002</year>) <volume>30</volume>:<page-range>207&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xing</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Han</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Multiple datasets to explore the tumor microenvironment of cutaneous squamous cell carcinoma</article-title>. <source>Math Biosci Eng</source>. (<year>2022</year>) <volume>19</volume>:<page-range>5905&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3934/mbe.2022276</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>He</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Comprehensive bioinformatics analysis reveals the crosstalk genes and immune relationship between the systemic lupus erythematosus and venous thromboembolism</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1196064</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1196064</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>X</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Identification of four-gene signature to diagnose osteoarthritis through bioinformatics and machine learning methods</article-title>. <source>Cytokine</source>. (<year>2023</year>) <volume>169</volume>:<elocation-id>156300</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cyto.2023.156300</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xe4;nzelmann</surname> <given-names>S</given-names>
</name>
<name>
<surname>Castelo</surname> <given-names>R</given-names>
</name>
<name>
<surname>Guinney</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>GSVA: gene set variation analysis for microarray and RNA-seq data</article-title>. <source>BMC Bioinf</source>. (<year>2013</year>) <volume>14</volume>:<elocation-id>7</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2105-14-7</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tamayo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mootha</surname> <given-names>VK</given-names>
</name>
<name>
<surname>Mukherjee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ebert</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Gillette</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2005</year>) <volume>102</volume>:<page-range>15545&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langfelder</surname> <given-names>P</given-names>
</name>
<name>
<surname>Horvath</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>WGCNA: an R package for weighted correlation network analysis</article-title>. <source>BMC Bioinf</source>. (<year>2008</year>) <volume>9</volume>:<elocation-id>559</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>N&#xfa;&#xf1;ez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Steyerberg</surname> <given-names>EW</given-names>
</name>
<name>
<surname>N&#xfa;&#xf1;ez</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>[Regression modeling strategies]</article-title>. <source>Rev Esp Cardiol</source>. (<year>2011</year>) <volume>64</volume>:<page-range>501&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.recesp.2011.01.019</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bindea</surname> <given-names>G</given-names>
</name>
<name>
<surname>Mlecnik</surname> <given-names>B</given-names>
</name>
<name>
<surname>Tosolini</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kirilovsky</surname> <given-names>A</given-names>
</name>
<name>
<surname>Waldner</surname> <given-names>M</given-names>
</name>
<name>
<surname>Obenauf</surname> <given-names>AC</given-names>
</name>
<etal/>
</person-group>. <article-title>Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer</article-title>. <source>Immunity</source>. (<year>2013</year>) <volume>39</volume>:<page-range>782&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2013.10.003</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rodriguez</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lopes</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zuberi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Montojo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bader</surname> <given-names>GD</given-names>
</name>
<etal/>
</person-group>. <article-title>GeneMANIA update 2018</article-title>. <source>Nucleic Acids Res</source>. (<year>2018</year>) <volume>46</volume>:<fpage>W60</fpage>&#x2013;<lpage>w64</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gky311</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuleshov</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Rouillard</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Fernandez</surname> <given-names>NF</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title>. <source>Nucleic Acids Res</source>. (<year>2016</year>) <volume>44</volume>:<page-range>W90&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bian</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>RNA-seq and network analysis reveal unique chemokine activity signatures in the synovial tissue of patients with rheumatoid arthritis</article-title>. <source>Front Med (Lausanne)</source>. (<year>2022</year>) <volume>9</volume>:<elocation-id>799440</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmed.2022.799440</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smolen</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Insights into the treatment of rheumatoid arthritis: A paradigm in medicine</article-title>. <source>J Autoimmun</source>. (<year>2020</year>) <volume>110</volume>:<elocation-id>102425</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jaut.2020.102425</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wehmeyer</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pap</surname> <given-names>T</given-names>
</name>
<name>
<surname>Buckley</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Naylor</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>The role of stromal cells in inflammatory bone loss</article-title>. <source>Clin Exp Immunol</source>. (<year>2017</year>) <volume>189</volume>:<fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cei.12979</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ammari</surname> <given-names>M</given-names>
</name>
<name>
<surname>Presumey</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ponsolles</surname> <given-names>C</given-names>
</name>
<name>
<surname>Roussignol</surname> <given-names>G</given-names>
</name>
<name>
<surname>Roubert</surname> <given-names>C</given-names>
</name>
<name>
<surname>Escriou</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Delivery of miR-146a to ly6C(high) monocytes inhibits pathogenic bone erosion in inflammatory arthritis</article-title>. <source>Theranostics</source>. (<year>2018</year>) <volume>8</volume>:<page-range>5972&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/thno.29313</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Misharin</surname> <given-names>AV</given-names>
</name>
<name>
<surname>Cuda</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Saber</surname> <given-names>R</given-names>
</name>
<name>
<surname>Turner</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Gierut</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Haines</surname> <given-names>GK</given-names>
</name>
<etal/>
</person-group>. <article-title>Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in mice</article-title>. <source>Cell Rep</source>. (<year>2014</year>) <volume>9</volume>:<fpage>591</fpage>&#x2013;<lpage>604</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2014.09.032</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>K</given-names>
</name>
<name>
<surname>Slowikowski</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fonseka</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Rao</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry</article-title>. <source>Nat Immunol</source>. (<year>2019</year>) <volume>20</volume>:<page-range>928&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-019-0378-1</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azizi</surname> <given-names>G</given-names>
</name>
<name>
<surname>Jadidi-Niaragh</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mirshafiey</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis</article-title>. <source>Int J Rheum Dis</source>. (<year>2013</year>) <volume>16</volume>:<page-range>243&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/1756-185x.12132</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prevosto</surname> <given-names>C</given-names>
</name>
<name>
<surname>Goodall</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Hill Gaston</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Cytokine secretion by pathogen recognition receptor-stimulated dendritic cells in rheumatoid arthritis and ankylosing spondylitis</article-title>. <source>J Rheumatol</source>. (<year>2012</year>) <volume>39</volume>:<page-range>1918&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3899/jrheum.120208</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname> <given-names>H</given-names>
</name>
<name>
<surname>Nakashima</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Okazaki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mawatari</surname> <given-names>T</given-names>
</name>
<name>
<surname>Fukushi</surname> <given-names>JI</given-names>
</name>
<name>
<surname>Kaibara</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis</article-title>. <source>Ann Rheum Dis</source>. (<year>2008</year>) <volume>67</volume>:<page-range>1299&#x2013;304</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/ard.2007.080341</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Estrada-Capetillo</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez-Castro</surname> <given-names>B</given-names>
</name>
<name>
<surname>Monsiv&#xe1;is-Urenda</surname> <given-names>A</given-names>
</name>
<name>
<surname>Alvarez-Quiroga</surname> <given-names>C</given-names>
</name>
<name>
<surname>Layseca-Espinosa</surname> <given-names>E</given-names>
</name>
<name>
<surname>Abud-Mendoza</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus</article-title>. <source>Clin Dev Immunol</source>. (<year>2013</year>) <volume>2013</volume>:<elocation-id>584303</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2013/584303</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moret</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Hack</surname> <given-names>CE</given-names>
</name>
<name>
<surname>van der Wurff-Jacobs</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Radstake</surname> <given-names>TR</given-names>
</name>
<name>
<surname>Lafeber</surname> <given-names>FP</given-names>
</name>
<name>
<surname>van Roon</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells</article-title>. <source>Arthritis Rheumatol</source>. (<year>2014</year>) <volume>66</volume>:<page-range>1176&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/art.38338</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood</article-title>. <source>Ann Rheum Dis</source>. (<year>2015</year>) <volume>74</volume>:<page-range>1293&#x2013;301</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/annrheumdis-2013-204228</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duxbury</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Ito</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zinner</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Ashley</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Whang</surname> <given-names>EE</given-names>
</name>
</person-group>. <article-title>Retraction Note: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine</article-title>. <source>Oncogene</source>. (<year>2023</year>) <volume>42</volume>:<fpage>1157</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41388-023-02627-4</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells <italic>in vitro</italic> and <italic>in vivo</italic>: implication of RRM2 in angiogenesis</article-title>. <source>Mol Cancer</source>. (<year>2009</year>) <volume>8</volume>:<elocation-id>11</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1476-4598-8-11</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>B</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Yen</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Ribonucleotide reductase inhibitors and future drug design</article-title>. <source>Curr Cancer Drug Targets</source>. (<year>2006</year>) <volume>6</volume>:<page-range>409&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/156800906777723949</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposome&#x2212;protamine-DNA-siRNA complex with cell permeable peptides</article-title>. <source>Int J Mol Med</source>. (<year>2018</year>) <volume>42</volume>:<page-range>2393&#x2013;402</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/ijmm.2018.3815</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Nie</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Integrated bioinformatics analysis and experimental validation reveals hub genes of rheumatoid arthritis</article-title>. <source>Exp Ther Med</source>. (<year>2023</year>) <volume>26</volume>:<fpage>480</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/etm.2023.12179</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>YR</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>JQ</given-names>
</name>
<name>
<surname>Li</surname> <given-names>XF</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Identification and preliminary validation of synovial tissue-specific genes and their-mediated biological mechanisms in rheumatoid arthritis</article-title>. <source>Int Immunopharmacol</source>. (<year>2023</year>) <volume>117</volume>:<elocation-id>109997</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2023.109997</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>P</given-names>
</name>
<name>
<surname>Zhaxi</surname> <given-names>B</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>DLG7/DLGAP5 as a potential therapeutic target in gastric cancer</article-title>. <source>Chin Med J (Engl)</source>. (<year>2022</year>) <volume>135</volume>:<page-range>1616&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/cm9.0000000000001859</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>X</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Knockdown of DLGAP5 suppresses cell proliferation, induces G(2)/M phase arrest and apoptosis in ovarian cancer</article-title>. <source>Exp Ther Med</source>. (<year>2021</year>) <volume>22</volume>:<fpage>1245</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/etm.2021.10680</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Du</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of biomarkers associated with synovitis in rheumatoid arthritis by bioinformatics analyses</article-title>. <source>Biosci Rep</source>. (<year>2020</year>) <volume>40</volume>(<issue>9</issue>):<page-range>BSR20201713</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/bsr20201713</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>